← Back to Search

Behavioural Intervention

Monitoring System for Pregnancy Complications (MOMS Trial)

N/A
Recruiting
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Greater than 28 weeks pregnant
Age 18 years or older
Must not have
Severe cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 weeks postpartum
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to help pregnant women, especially minority groups like African-Americans and Spanish-speaking Latinas, better recognize warning signs of pregnancy-related complications and seek medical help."

Who is the study for?
This trial is for pregnant individuals over 28 weeks, identifying as Black/African American or Hispanic/Latino. Participants must be able to read and speak English or Spanish respectively, plan to deliver at specified NewYork-Presbyterian hospitals, be 18+, and receive healthcare in the U.S. Those with severe cognitive issues, major psychiatric illness, or terminal illnesses cannot join.
What is being tested?
The trial is testing a Maternal Outcome Monitoring and Support system designed to help patients recognize warning signs of pregnancy-related complications that could lead to death, especially among minority groups.
What are the potential side effects?
Since this intervention involves monitoring systems rather than medication or invasive procedures, traditional side effects are not applicable. However, there may be psychological impacts from increased awareness of potential complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am more than 28 weeks pregnant.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have significant memory or thinking problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 weeks postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 weeks postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient activation
Secondary study objectives
Knowledge of pregnancy related death warning signs

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MOMS interventionExperimental Treatment1 Intervention
Participants in this condition will receive the MOMS symptom monitoring and decision support intervention. This is a single arm trial.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,767,045 Total Patients Enrolled
1 Trials studying Maternal Death
58,747 Patients Enrolled for Maternal Death
National Institute on Minority Health and Health Disparities (NIMHD)NIH
444 Previous Clinical Trials
1,413,431 Total Patients Enrolled
2 Trials studying Maternal Death
1,858 Patients Enrolled for Maternal Death
~53 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top